Improving analysis of T-cell receptor sequencing data

Statistical methods for TCR-sequencing experiments

NIH-funded research University of Wisconsin-Madison · NIH-11119143

This study is working on improving how we analyze T-cell receptor data to better understand how our immune system fights infections and diseases, especially in conditions like autoimmune diseases and cancer, so we can find important T-cell types that help us respond to these health issues.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Wisconsin-Madison NIH-funded
Lab location1 site (Madison, United States)
Project IDNIH-11119143 on NIH RePORTER

What this research studies

This research focuses on enhancing the analysis of T-cell receptor (TCR) sequencing data, which is crucial for understanding how the immune system responds to infections and diseases. By developing new statistical methods, the project aims to ensure that important functional TCRs are not overlooked during data processing. The goal is to identify specific TCR clonotypes that could significantly influence immune responses related to various conditions, including autoimmune diseases and cancer. This work will leverage advanced technologies for TCR profiling to provide deeper insights into individual immune responses.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals with autoimmune diseases or those undergoing treatment for cancer, as their TCR profiles may provide valuable insights.

Not a fit: Patients without autoimmune conditions or cancer may not receive direct benefits from this research.

Why it matters

Potential benefit: If successful, this research could lead to better understanding and treatment of autoimmune diseases and improve immune response strategies against infections and cancer.

How similar studies have performed: Other research has shown promise in utilizing advanced statistical methods for TCR analysis, indicating that this approach could yield significant advancements in understanding immune responses.

Where this research is happening

Madison, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.